PRZOOM - /newswire/ -
Newark, DE, United States, 2008/11/26 - Accugenix Announces New CEO & President, Retains Former as R&D VP Former COO Roger Nalepa takes the reins and former CEO Doug Smith refocuses on R&D.
Accugenix, Inc. publicly announced today the promotion of former COO, Roger Nalepa, to the position of CEO & President, and the reassignment of former CEO Doug Smith to Vice President of Research & Development. Specializing in genetic microbial identification, the Delaware-based DNA sequencing lab described the recent reorganization as rejuvenation for both its strategic leadership and its exemplary cutting-edge technology.
"Doug and I have changed roles to command positions that capitalize on our strengths to further drive the business," said Nalepa, whose extensive 30-year history of management experience includes executive-level positions at Hewlett Packard and Agilent Technologies. “Our skill sets complement one another very well; Doug’s entrepreneurship and technical expertise have made him a leader in cutting-edge technology, whereas my management and international leadership experience have prepared me to coordinate our people to deliver our objectives and strategic vision.”
As CEO, Nalepa will provide strategic leadership for the company, working with the Board of Directors (presided over by Chairman Mark Martin) and the Executive Management Team to establish long-range goals, strategies and policies. He will assume fiduciary responsibility for protecting shareholder interests, and publicly represent Accugenix in the community. As R&D VP, Smith will direct all activities related to building the research and development function and its strategic direction. He will establish R&D initiatives for improving DNA sequencing assays, bacterial and fungal identification libraries, cost, and on-time delivery, continually innovating solutions to customer problems. Smith developed two microbial ID systems currently in use: he developed the fatty acid microbe ID system, while at Hewlett-Packard, and more recently, he developed the sequencing-based ID system MicroSEQ™ while at Applied Biosystems.
A founding Board member of Accugenix, Smith brought Nalepa on board nearly a year ago to utilize his business leadership savvy and has since helped familiarize him with the industry and the company’s focused, highly-specialized services. Nalepa agreed: “I’ve been with Accugenix long enough to feel very confident with my grasp on the technology, the industry, and our challenges and strategies. Doug has paved the way for this smooth transition aimed to energize the company and return him to what he does best and loves most—R&D.”
Indeed, Smith is excited to return to his passion and feels confident with Nalepa taking the reins: “Accugenix is looking to expand, and Roger has the leadership experience and demonstrated success for such a transition.”
As for Accugenix’s future, Nalepa plans to continue process improvements that support the company’s industry-leading reputation for genetic microbial identification: “we have always been and will continue to be a focused lab; we do sequence identification and we do it really well. We are the industry leader because we continue to use technology to solve customer problems—increasing quality and reducing cost to maintain consistent high performance for our customers.”